Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F3 | P13726 | 4/20 | 1.00 |
| ▸ | SIRT5 | Q9NXA8 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | OXTR | P30559 | 1/20 | 1.00 |
| ▸ | AVPR1A | P37288 | 1/20 | 1.00 |
| ▸ | CD81 | P60033 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.75 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.75 |
| ▸ | POLB | P06746 | 3/20 | 0.75 |
| ▸ | PTPN6 | P29350 | 3/20 | 0.75 |
| ▸ | RELA | Q04206 | 3/20 | 0.75 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.75 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.75 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.75 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.75 |
| ▸ | PTPRC | P08575 | 2/20 | 0.75 |
| ▸ | PTPRF | P10586 | 2/20 | 0.75 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.75 |
| ▸ | CES1 | P23141 | 2/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Echinocystic Acid SCHEMBL741321 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL18712289 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL4454760 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL13629642 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL18712288 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL18704435 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL17030511 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL42864 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL21892162 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR | |
| Echinocystic Acid SCHEMBL30168683 | 1.00 | F3 (1.00) | F3SIRT5CYP3A4MAPK1OXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | F3 5/4885SIRT5 2156/4885CYP3A4 928/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | F3 11/4885SIRT5 1999/4885CYP3A4 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.